Regencell Bioscience Holdings Limited (RGC) vs Supernus Pharmaceuticals, Inc. (SUPN)
Regencell Bioscience Holdings Limited and Supernus Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Regencell Bioscience Holdings Limited is the larger, with a market value of $3.1B against $2.5B — 1.2× the size. Regencell Bioscience Holdings Limited has the higher net margin (0.00% vs −13.2%) and the higher return on invested capital (0.00% vs −12.4%). Across the 10 metrics below, Regencell Bioscience Holdings Limited leads on 5 and Supernus Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | RGC | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | — | 88.07% | 53.94% |
| Operating margin | — | (15.71%) | 0.00% |
| Net margin | 0.00% | (13.23%) | 0.00% |
| Free cash flow margin | 0.00% | 2.21% | 0.00% |
| Return on equity | 0.00% | (10.49%) | (0.40%) |
| Return on assets | 0.00% | (7.82%) | (3.32%) |
| Return on invested capital | 0.00% | (12.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack